When we used the first cutoff value, MRP1 overexpression was observed in the relapsed ALL patients but, according to the alternative cutoff, no cases of ALL in the relapsed or NR group showed overexpression. This evidence concerns the gene ABCC1 and acute lymphoblastic leukemia.